Cytokines participate in many physiological processes including the regulation of immune and inflammatory responses. These effector molecules are produced transiently and locally controlling the amplitude and duration of the response. A variety of experiments has shown that excessive or insufficient production may significantly contribute to the pathophysiology of a range of diseases. Particularly cytokines released by CD4+ T cells at the onset of an immune response are thought to be decisive for pathological or physiological consequences. The meeting in Budapest was focussed on cytokines known to contribute to the pathophysiology of autoimmune diseases, infectious diseases and allograft rejection (e.g., IL-1, IL-4, IL-6, IL-10, IL-12, TNF-α and IFN-α,-β,-γ). A central role for IFN-γ in autoimmunity was suggested by blocking experimentsin vivo using monoclonal antibodies and soluble forms of the IFN-γ receptor (IFN-γsR). These agents ameliorated disease development in a variety of experimental autoimmune diseases in rodents. In a mouse model for the human disease Myasthenia gravis, IFN-α was found to reduce both the incidence and progression of the disease. Treatment of R. aurantiacus-infected mice with anti-IL-4 monoclonal antibodies (mAbs) was reported to interfere with the regression of granulomas in spleen and liver, most likely through inadequate IL-4-mediated suppression of IFN-γ production. In addition, it was shown that mice with disrupted IFN-γ R genes died rapidly after infection with the BCG strain of M. bovis, whereas normal mice survived the infection. IL-12 was found to be the main inductor of IFN-γ during the lethal Shwartzman reaction. TNF-α was identified as the principal cause of mortality after the second injection with LPS. In a variety of studies examining the role of cytokines in the pathogenesis of AIDS, much attention was given to thein vitro effects of HIV-1 and/or the HIV-1 viral membrane protein gp120 on triggering cytokine production by peripheral blood leukocytes (PBLs) and purified monocytes/macrophages (Mø) originating from healthy donors. Gp120 as a sole agent significantly suppressed IFN-γ production by mitogen-stimulated PBLs and induced the production of IFN-α in cultures of normal human peripheral blood mononuclear cells (PBMCs). In a human macrophage cell line, TNF-α exerted a stimulatory effect on viral replication and programmed cell death induced by HIV-1 which was potentiated by the simultaneous incubation with IFN-γ. Upon transfection of human PBLs and CD4+ T cells with a retroviral vector encoding human IFN-β, a notable reduction in reverse transcriptase activity after HIV-1 challenge was observed. Gp120 was also found to induce both IL-6 and TNF-α expression and to induce morphological changes reminiscent for apoptosis in primary astrocytes and in a re-aggregated human brain cell model, suggesting a role for these cytokines in the neuropathology of AIDS dementia. Moreover, data were presented indicating that cytokine-induced expression of cell adhesion molecules (e.g., ICAM-1) in HIV-1 infected U 937 cells leads to high level incorporation of this molecule in the membrane of the viral progeny which may play a role in the attachment of such virions to CD4-negative cells.
KeywordsHuman Peripheral Blood Mononuclear Cell Reverse Transcriptase Activity Simultaneous Incubation Human Brain Cell Normal Human Peripheral Blood
Unable to display preview. Download preview PDF.
- 9.De Waal Malefyt R, Haanen J, Spits H, Roncarolo M-G, Te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, De Vries JE. Il-10 and viral Il-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II MHC expression. J Exp Med 1991; 174: 915–24.PubMedGoogle Scholar
- 10.De Waal Malefyt R, Figdor CG, Huijbers R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, De Vries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151: 6370–81.PubMedGoogle Scholar
- 15.Häyry P, Ferry B, Leszczynski D, Manca F, Jaakkola M, Halttunen J, Von Willebrand E, Schellekens H, Van der Meide PH. Generation and breakdown of a vicious cycle in context of acute allograft rejection. Transpl Proc 1986; XVIII: 52–62.Google Scholar
- 24.Lahdevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med (1990) 85: 289–91.Google Scholar
- 30.Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature (Lond.) 1993; 362: 248–50.Google Scholar
- 36.Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor apha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990; 172: 151–8.PubMedGoogle Scholar
- 38.Roux-Lombard P, Modoux C, Crushaud A, Dayer G-M. Purified blood monocytes from HIV-1-infected patients produce high levels of TNF-alpha and IL-1. Clin Immunol Immunopathol 1989; 84: 374–84.Google Scholar
- 46.Strom TB, Kupiec-Weglinski JW, Heidecke CD, Tilney NL. The cellular and molecular basis of allograft rejection: fact and fancy. Transpl Proc 1985; XVII: 801–5.Google Scholar
- 47.The IFNB multiple sclerosis study group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43: 655–61.Google Scholar
- 50.Uitdehaag BMJ, De Groot CJA, Kreike A, Van der Meide PH, Polman CH, Dijkstra CD. The significance ofin-situ Ia antigen expression in the pathogenesis of autoimmune central nervous system disease. J Autoimmunity 1993; 6: 323–35.Google Scholar
- 53.Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i: 355–7.Google Scholar